New York, September 9th – Branford Castle Partners, a New York City-based private equity firm, today announced the acquisition of Pulse Veterinary Technologies, LLC. This is the twelfth acquisition overall for Branford’s fund, which closed in late 2016, and its eighth platform investment.
Headquartered in Alpharetta, GA, with subsidiary operations in Japan, PulseVet is the veterinary industry’s leading provider of shock wave therapy devices.
Founded in 2009, PulseVet has a large installed base of equipment worldwide, and serves most leading equine veterinarians in North America plus many veterinary schools.
“With three great platform acquisitions since August 1 – a Triple Crown if you will – we have completed platform investing from our current fund at a gallop,” said David A. Castle, Managing Partner of Branford Castle Partners.
PulseVet is led by CEO Adrian Lock, a 25-plus-year industry veteran. He is supported by a strong team of tenured executive leaders. “We are excited to partner with Branford to accelerate new geographic and customer expansion and potential acquisitions,” said Lock.
Terms of the transaction were not disclosed.